NovoCure Ltd — Director's Dealing 2015

Oct 1, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01

Reporting Person: MYLOD ROBERT J JR (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Buy Ordinary Shares	$6.72	2022-09-29	Ordinary Shares (162607)		Direct
Series H Convertible Preferred Shares	$		Ordinary Shares (148114)		Direct

Footnotes

F1: Options to buy 121,955 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 40,652 ordinary shares will vest and become exercisable on September 29, 2016, subject to Mr. Mylod's continued service through such date.

F2: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series will automatically convert into ordinary shares upon consummation of the issuer's initial public offering.

F3: N/A